Isofenal

Ketoprofen, the active ingredient in Isofenal, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an injection for intramuscular use. It treats pain and inflammation in conditions such as rheumatoid arthritis, osteoarthritis and acute musculoskeletal pain. Isofenal is supplied in the European market and is prescribed for short‑term management of moderate to severe pain and inflammatory disorders.

GNH USA supplies Isofenal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketoprofen acts on inflammatory pathways and is employed for several musculoskeletal and rheumatic conditions. - Rheumatoid arthritis: reduces joint pain, swelling and stiffness. - Osteoarthritis: alleviates chronic joint discomfort and improves mobility. - Acute musculoskeletal pain: provides rapid relief of pain from sprains, strains or trauma. - Post‑operative pain: helps control pain after surgical procedures. - Ankylosing spondylitis: diminishes inflammatory back pain and stiffness.

Ketoprofen may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Dyspepsia: indigestion or heartburn. - Headache: transient cranial discomfort. - Dizziness: occasional light‑headedness. - Injection site pain: local tenderness or erythema. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Gastrointestinal bleeding: ulceration or hemorrhage. - Renal impairment: reduced kidney function or failure. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Stevens‑Johnson syndrome: severe skin reactions. - Anaphylaxis: life‑threatening allergic response. - Cardiovascular thrombotic events: increased risk of heart attack or stroke.

Before using Isofenal, consider the following safety measures. - Renal function: assess baseline kidney status and monitor during therapy. - Gastrointestinal risk: avoid in patients with active peptic ulcer disease or recent GI bleeding. - Cardiovascular risk: use cautiously in individuals with coronary artery disease or hypertension. - Pregnancy: avoid unless the potential benefit justifies the risk; safety data are limited. - Concomitant anticoagulants: monitor for enhanced bleeding tendency. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ketoprofen can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding potential.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may reduce renal perfusion and function. - Diuretics: increased risk of renal impairment. - Lithium: ketoprofen can raise serum lithium concentrations, requiring level checks.